Comparing the effect of tranexamic acid needling versus tranexamic acid injections in melasma
Phase 2
- Conditions
- Health Condition 1: L818- Other specified disorders of pigmentation
- Registration Number
- CTRI/2024/03/064275
- Lead Sponsor
- Vinayaka Missions Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with clinical diagnosis of melasma
Patients who are
willing to participate in the study
Exclusion Criteria
Patients allergic to Tranaxemic acid
Patients with predisposition to keloids
Pregnant and lactating mothers
Patients with history of bleeding disorders use of oral anticoagulant drugs
Patients under oral contraceptive pills hormonal replacement therapy at the time of or during the past 12 months of study
Patients with a history of treatment for melasma in the past 6 weeks in any form
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare the clinical response by mMASI and PtGA score <br/ ><br>to microneedling with tranexamic acid <br/ ><br>and microinjections with tranexamic acid in treatment of melasma <br/ ><br>Timepoint: every 2 weeks for 3 months, and at the end of 6 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Treatment side effectsTimepoint: Every 4 weeks for 3 months and at the end of 6 months